Published in J Neural Eng on August 21, 2009
Neural control of cursor trajectory and click by a human with tetraplegia 1000 days after implant of an intracortical microelectrode array. J Neural Eng (2011) 2.80
Mechanically adaptive intracortical implants improve the proximity of neuronal cell bodies. J Neural Eng (2011) 1.33
Progress towards biocompatible intracortical microelectrodes for neural interfacing applications. J Neural Eng (2014) 1.29
Failure mode analysis of silicon-based intracortical microelectrode arrays in non-human primates. J Neural Eng (2013) 1.27
Implant size and fixation mode strongly influence tissue reactions in the CNS. PLoS One (2011) 1.24
Mechanically-compliant intracortical implants reduce the neuroinflammatory response. J Neural Eng (2014) 1.24
The surface immobilization of the neural adhesion molecule L1 on neural probes and its effect on neuronal density and gliosis at the probe/tissue interface. Biomaterials (2010) 1.11
In vivo two-photon microscopy reveals immediate microglial reaction to implantation of microelectrode through extension of processes. J Neural Eng (2012) 1.11
In vivo deployment of mechanically adaptive nanocomposites for intracortical microelectrodes. J Neural Eng (2011) 1.10
Reduction of neurovascular damage resulting from microelectrode insertion into the cerebral cortex using in vivo two-photon mapping. J Neural Eng (2010) 1.09
A review of organic and inorganic biomaterials for neural interfaces. Adv Mater (2014) 1.05
Biocompatibility of intracortical microelectrodes: current status and future prospects. Front Neuroeng (2010) 1.05
Bridging the Divide between Neuroprosthetic Design, Tissue Engineering and Neurobiology. Front Neuroeng (2010) 1.03
Brain tissue responses to neural implants impact signal sensitivity and intervention strategies. ACS Chem Neurosci (2015) 0.99
The utility of multichannel local field potentials for brain-machine interfaces. J Neural Eng (2013) 0.96
Carbon nanotube-based multi electrode arrays for neuronal interfacing: progress and prospects. Front Neural Circuits (2013) 0.96
In situ characterization of the brain-microdevice interface using device-capture histology. J Neurosci Methods (2011) 0.95
Chronic intracortical microelectrode arrays induce non-uniform, depth-related tissue responses. J Neural Eng (2013) 0.95
Floating light-activated microelectrical stimulators tested in the rat spinal cord. J Neural Eng (2011) 0.94
Organic electrode coatings for next-generation neural interfaces. Front Neuroeng (2014) 0.90
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue? Front Pharmacol (2014) 0.90
Recording evoked potentials during deep brain stimulation: development and validation of instrumentation to suppress the stimulus artefact. J Neural Eng (2012) 0.89
The density difference between tissue and neural probes is a key factor for glial scarring. Sci Rep (2013) 0.89
Novel interfaces for light directed neuronal stimulation: advances and challenges. Int J Nanomedicine (2014) 0.87
Electrode impedance analysis of chronic tungsten microwire neural implants: understanding abiotic vs. biotic contributions. Front Neuroeng (2014) 0.87
Long-term changes in the material properties of brain tissue at the implant-tissue interface. J Neural Eng (2013) 0.87
A simple implantation method for flexible, multisite microelectrodes into rat brains. Front Neuroeng (2013) 0.86
A comparison of neuroinflammation to implanted microelectrodes in rat and mouse models. Biomaterials (2014) 0.84
Adaptive movable neural interfaces for monitoring single neurons in the brain. Front Neurosci (2011) 0.84
The Effect of Residual Endotoxin Contamination on the Neuroinflammatory Response to Sterilized Intracortical Microelectrodes. J Mater Chem B Mater Biol Med (2014) 0.83
Evaluation of poly(3,4-ethylenedioxythiophene)/carbon nanotube neural electrode coatings for stimulation in the dorsal root ganglion. J Neural Eng (2014) 0.83
Astrocyte-derived thrombospondin-2 is critical for the repair of the blood-brain barrier. Am J Pathol (2011) 0.83
Cellular modulation of polymeric device surfaces: promise of adult stem cells for neuro-prosthetics. Front Neurosci (2011) 0.83
The fate of ultrafast degrading polymeric implants in the brain. Biomaterials (2011) 0.83
Influence of probe flexibility and gelatin embedding on neuronal density and glial responses to brain implants. PLoS One (2015) 0.81
Elastomeric and soft conducting microwires for implantable neural interfaces. Soft Matter (2015) 0.81
Neural origin of evoked potentials during thalamic deep brain stimulation. J Neurophysiol (2013) 0.80
Insertion of linear 8.4 μm diameter 16 channel carbon fiber electrode arrays for single unit recordings. J Neural Eng (2015) 0.80
Compliant intracortical implants reduce strains and strain rates in brain tissue in vivo. J Neural Eng (2015) 0.80
Host response to microgel coatings on neural electrodes implanted in the brain. J Biomed Mater Res A (2013) 0.80
Stability and selectivity of a chronic, multi-contact cuff electrode for sensory stimulation in human amputees. J Neural Eng (2015) 0.79
An array of highly flexible electrodes with a tailored configuration locked by gelatin during implantation-initial evaluation in cortex cerebri of awake rats. Front Neurosci (2015) 0.79
Protease-degradable PEG-maleimide coating with on-demand release of IL-1Ra to improve tissue response to neural electrodes. Biomaterials (2015) 0.79
The roles of blood-derived macrophages and resident microglia in the neuroinflammatory response to implanted intracortical microelectrodes. Biomaterials (2014) 0.79
Evolution of optogenetic microdevices. Neurophotonics (2015) 0.79
Preventing neuronal damage and inflammation in vivo during cortical microelectrode implantation through the use of poloxamer P-188. J Neural Eng (2013) 0.79
The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation. Biomaterials (2014) 0.79
Intact histological characterization of brain-implanted microdevices and surrounding tissue. J Vis Exp (2013) 0.78
Design and in vivo evaluation of more efficient and selective deep brain stimulation electrodes. J Neural Eng (2015) 0.78
Nanoparticle-based evaluation of blood-brain barrier leakage during the foreign body response. J Neural Eng (2013) 0.78
Instrumentation to record evoked potentials for closed-loop control of deep brain stimulation. Conf Proc IEEE Eng Med Biol Soc (2011) 0.78
Contributions of Subsurface Cortical Modulations to Discrimination of Executed and Imagined Grasp Forces through Stereoelectroencephalography. PLoS One (2016) 0.77
Mechanical and Biological Interactions of Implants with the Brain and Their Impact on Implant Design. Front Neurosci (2016) 0.77
In Vivo Electrochemical Analysis of a PEDOT/MWCNT Neural Electrode Coating. Biosensors (Basel) (2015) 0.76
Bioactive Agarose Carbon-Nanotube Composites are Capable of Manipulating Brain-Implant Interface. J Appl Polym Sci (2014) 0.76
Implications of chronic daily anti-oxidant administration on the inflammatory response to intracortical microelectrodes. J Neural Eng (2015) 0.76
Injectable 3-D fabrication of medical electronics at the target biological tissues. Sci Rep (2013) 0.76
Neuroadhesive L1 coating attenuates acute microglial attachment to neural electrodes as revealed by live two-photon microscopy. Biomaterials (2016) 0.76
A novel wireless recording and stimulating multichannel epicortical grid for supplementing or enhancing the sensory-motor functions in monkey (Macaca fascicularis). Front Syst Neurosci (2015) 0.75
Neurobiochemical changes in the vicinity of a nanostructured neural implant. Sci Rep (2016) 0.75
Attenuation of the in vitro neurotoxicity of 316L SS by graphene oxide surface coating. Mater Sci Eng C Mater Biol Appl (2017) 0.75
A Nanoscale Interface Promoting Molecular and Functional Differentiation of Neural Cells. Sci Rep (2016) 0.75
Histological evaluation of a chronically-implanted electrocorticographic electrode grid in a non-human primate. J Neural Eng (2016) 0.75
Influence of resveratrol release on the tissue response to mechanically adaptive cortical implants. Acta Biomater (2015) 0.75
A method for systematic electrochemical and electrophysiological evaluation of neural recording electrodes. J Vis Exp (2014) 0.75
Engineering therapies in the CNS: what works and what can be translated. Neurosci Lett (2012) 0.75
Measurement of evoked potentials during thalamic deep brain stimulation. Brain Stimul (2014) 0.75
Chronic in vivo stability assessment of carbon fiber microelectrode arrays. J Neural Eng (2016) 0.75
A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science (2007) 18.96
Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med (2012) 10.16
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet (2009) 6.83
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet (2008) 6.72
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet (2005) 4.45
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci (2002) 4.15
5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat Neurosci (2011) 4.15
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet (2003) 4.07
Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch Neurol (2004) 3.39
A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Mol Cell (2004) 3.26
Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins. Neuron (2004) 3.04
The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J Neurosci (2006) 2.77
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2010) 2.64
Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS System Pivotal trial. Epilepsia (2014) 2.60
Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat Cell Biol (2002) 2.50
Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem (2006) 2.50
Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem (2004) 2.46
Real-time magnetic resonance-guided stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy. Neurosurgery (2014) 2.41
Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats. J Neurosci (2008) 2.34
A liposomal nanoscale contrast agent for preclinical CT in mice. AJR Am J Roentgenol (2006) 2.21
Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. J Biol Chem (2003) 2.21
Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment. J Am Geriatr Soc (2013) 2.11
The functional neuroanatomy of dystonia. Neurobiol Dis (2011) 2.08
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J Neurosci (2002) 2.05
Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry (2012) 1.83
Better object recognition and naming outcome with MRI-guided stereotactic laser amygdalohippocampotomy for temporal lobe epilepsy. Epilepsia (2014) 1.81
The role of aligned polymer fiber-based constructs in the bridging of long peripheral nerve gaps. Biomaterials (2008) 1.80
Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet (2010) 1.79
HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis. Hum Mol Genet (2002) 1.79
LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. J Neuropathol Exp Neurol (2006) 1.72
Topography, cell response, and nerve regeneration. Annu Rev Biomed Eng (2010) 1.70
A low-cost multielectrode system for data acquisition enabling real-time closed-loop processing with rapid recovery from stimulation artifacts. Front Neuroeng (2009) 1.69
Implanted neural interfaces: biochallenges and engineered solutions. Annu Rev Biomed Eng (2009) 1.67
Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. Hum Mol Genet (2002) 1.67
Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J Biol Chem (2004) 1.58
RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11alpha signaling. J Biol Chem (2004) 1.57
A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning. J Neurosci (2009) 1.57
Adenosine A(2A) receptor mediates microglial process retraction. Nat Neurosci (2009) 1.56
Rab11a and myosin Vb regulate recycling of the M4 muscarinic acetylcholine receptor. J Neurosci (2002) 1.54
Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J Neurosci (2002) 1.53
Assessment of brain shift related to deep brain stimulation surgery. Stereotact Funct Neurosurg (2007) 1.49
Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc Natl Acad Sci U S A (2009) 1.48
Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J Biol Chem (2011) 1.48
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet (2012) 1.46
Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J Neurosci (2003) 1.45
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment. Ann Neurol (2007) 1.45
In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. Biomaterials (2005) 1.45
Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes. Brain Res (2007) 1.44
Munc18 interacting proteins: ADP-ribosylation factor-dependent coat proteins that regulate the traffic of beta-Alzheimer's precursor protein. J Biol Chem (2003) 1.42
Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem (2005) 1.42
Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease. J Neurosci (2008) 1.39
Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res (2004) 1.35
Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers. Ann Neurol (2010) 1.34
CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension. Mol Cell Neurosci (2005) 1.32
Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats. J Physiol (2002) 1.32
Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models? Trends Pharmacol Sci (2009) 1.31
Biomechanical analysis of silicon microelectrode-induced strain in the brain. J Neural Eng (2005) 1.31
Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release (2003) 1.27
Huntingtin-associated protein 1 interacts with hepatocyte growth factor-regulated tyrosine kinase substrate and functions in endosomal trafficking. J Biol Chem (2002) 1.27
Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease. J Proteome Res (2009) 1.27
The impact of chronic blood-brain barrier breach on intracortical electrode function. Biomaterials (2013) 1.25
Deep brain stimulation for Parkinson's disease: surgical technique and perioperative management. Mov Disord (2006) 1.25
Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano (2011) 1.25
U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.23
A mutation of beta -actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and dystonia. Am J Hum Genet (2006) 1.20
Effect of modulating macrophage phenotype on peripheral nerve repair. Biomaterials (2012) 1.20
Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. Radiology (2009) 1.20
A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. J Control Release (2006) 1.19
Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor trafficking. EMBO J (2003) 1.19
Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. Parkinsonism Relat Disord (2009) 1.19
Famous face identification in temporal lobe epilepsy: support for a multimodal integration model of semantic memory. Cortex (2012) 1.18
Controlled release of anti-inflammatory agent alpha-MSH from neural implants. J Control Release (2005) 1.17
Long-circulating liposomal contrast agents for magnetic resonance imaging. Magn Reson Med (2006) 1.17
Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats. Neurobiol Dis (2005) 1.17
Closed-Loop, Multichannel Experimentation Using the Open-Source NeuroRighter Electrophysiology Platform. Front Neural Circuits (2013) 1.16
Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains. Mol Cell Proteomics (2010) 1.16
Differences between the effect of anisotropic and isotropic laminin and nerve growth factor presenting scaffolds on nerve regeneration across long peripheral nerve gaps. Biomaterials (2007) 1.15
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol (2012) 1.14
A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors. J Neurosci (2010) 1.14
Nanoscale neuro-integrative coatings for neural implants. Biomaterials (2005) 1.13
SPE-39 family proteins interact with the HOPS complex and function in lysosomal delivery. Mol Biol Cell (2008) 1.13
Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry. J Proteome Res (2008) 1.13
Proteomic identification of novel proteins associated with Lewy bodies. Front Biosci (2008) 1.13
Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma. Sci Transl Med (2012) 1.12
A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease. Neurobiol Dis (2009) 1.11
Targeted disruption of Huntingtin-associated protein-1 (Hap1) results in postnatal death due to depressed feeding behavior. Hum Mol Genet (2002) 1.10
Stimulus features underlying reduced tremor suppression with temporally patterned deep brain stimulation. J Neurophysiol (2011) 1.10
Chronically mad as a hatter: anticholinergics and Alzheimer's disease pathology. Ann Neurol (2003) 1.10
Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration. J Proteome Res (2010) 1.10